Automating Critical Drug Discovery Processes with NLP
Automating Critical Drug Discovery Processes with NLP - with Emmanuel Walckenaer of YSEOP and Dan Faggella from Emerj
Today’s guest is Emmanuel Walckenaer, CEO of YSEOP. A firm based in Paris, YSEOP focuses on natural language generation across financial services and life sciences industries. Emmanuel speaks with us this week about the applications of NLG when it comes to drug discovery and life sciences. Emmanuel also discusses some other life sciences and AI trends that he thinks are promising and some of the trends that he’s seen in his work in the life sciences space.